Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Earth Science Tech ( (ETST) ) has provided an update.
On January 5, 2026, Earth Science Tech announced it had engaged investor relations firm Hayden IR to lead a more expansive investor outreach and capital markets communications program, following the company’s receipt of FINRA 15c2-11 clearance. The move comes as Earth Science Tech reports strong performance in the first half of fiscal 2026, including $17.8 million in revenue, $1.4 million in net income, more than $1 million in operating cash flow and gross margins exceeding 70%, and seeks to better communicate its growth strategy and operating leverage across its pharmacy, telemedicine and direct-to-consumer businesses to institutional and retail investors. Management and Hayden IR emphasized that clearer messaging, enhanced market awareness and the CEO’s substantial cash-funded share ownership are intended to improve recognition of the company’s earnings potential and support its broader market repositioning, with implications for increased investor engagement and potentially stronger capital markets support.
The most recent analyst rating on (ETST) stock is a Hold with a $0.14 price target. To see the full list of analyst forecasts on Earth Science Tech stock, see the ETST Stock Forecast page.
Spark’s Take on ETST Stock
According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.
Earth Science Tech’s overall stock score reflects its strong financial recovery and growth, particularly in revenue and cash flow. The technical analysis indicates a bearish trend, but the valuation is reasonable. Recent corporate events further bolster the company’s outlook with significant asset and profit growth.
To see Spark’s full report on ETST stock, click here.
More about Earth Science Tech
Earth Science Tech, Inc. is a Florida-based strategic holding company focused on value creation through the acquisition, optimization and management of operating businesses in compounding pharmaceuticals, telemedicine, healthcare services, real estate development and direct-to-consumer retail. Its portfolio includes fully licensed compounding pharmacies RxCompoundStore.com and Mister Meds, telemedicine platform Peaks Curative and related healthcare services such as Las Villas Health Care and DOConsultations, real estate firm Avenvi which also oversees a $10 million share repurchase program, consumer brand MagneChef with patented cooking and BBQ tools, and its charitable arm Earth Science Foundation, which helps patients with prescription costs.
Average Trading Volume: 67,665
Technical Sentiment Signal: Sell
Current Market Cap: $38.04M
For a thorough assessment of ETST stock, go to TipRanks’ Stock Analysis page.